Impact of thyroglobulin changes on clinical outcomes of differentiated thyroid cancer with biochemical incomplete response.

Journal: Endocrine
Published Date: May 9, 2025

Abstract

PURPOSE: Partial patients with biochemical incomplete response (BIR) after initial therapy for differentiated thyroid cancer (DTC) may progress to structural recurrence during follow-up. For better-individualized care, this study analyzed predictors of structural recurrence in patients with BIR after initial radioactive iodine therapy (RAIT).

Authors

  • Xiaohui Li
    Department of Ophthalmology, Ningbo Yinzhou No.2 Hospital, Ningbo Urology and Nephrology Hospital, Ningbo, Zhejiang, China.
  • Tian Tian
    Laboratory Animal Center College of Animal Science Jilin University Changchun China.
  • Kexin Shi
    Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, China.
  • Chenyu Sun
    Department of Nuclear Medicine, West China Hospital of Sichuan University, Chengdu, China.
  • Rui Huang
    Department of Critical Care Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals